Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation.

Jha, Sunita R and Hannu, Malin K and Newton, Phillip J and Wilhelm, Kay and Hayward, Christopher S and Jabbour, Andrew and Kotlyar, Eugene and Keogh, Anne and Dhital, Kumud and Granger, Emily and Connellan, Mark and Jansz, Paul and Spratt, Phillip M and Montgomery, Elyn and Smith, Angela and Harkess, Michelle and Tunicliff, Peta and Davidson, Patricia M and Macdonald, Peter S (2017) Reversibility of Frailty After Bridge-to-Transplant Ventricular Assist Device Implantation or Heart Transplantation. Transplantation Direct, 3 (7). pp. e167. ISSN 2373-8731 (OA)

[thumbnail of JHA 2017 Reversibility_of_Frailty BridgeTx _ Heart Transplantation OA.pdf]
Preview
Text
JHA 2017 Reversibility_of_Frailty BridgeTx _ Heart Transplantation OA.pdf

Download (471kB) | Preview
Link to published document: https://doi.org/10.1097/TXD.0000000000000690

Abstract

BACKGROUND

We recently reported that frailty is independently predictive of increased mortality in patients with advanced heart failure referred for heart transplantation (HTx). The aim of this study was to assess the impact of frailty on short-term outcomes after bridge-to-transplant ventricular assist device (BTT-VAD) implantation and/or HTx and to determine if frailty is reversible after these procedures.

METHODS

Between August 2013 and August 2016, 100 of 126 consecutive patients underwent frailty assessment using Fried's Frailty Phenotype before surgical intervention: 40 (21 nonfrail, 19 frail) BTT-VAD and 77 (60 nonfrail, 17 frail) HTx-including 17 of the 40 BTT-VAD supported patients. Postprocedural survival, intubation time, intensive care unit, and hospital length of stay were compared between frail and nonfrail groups. Twenty-six frail patients were reassessed at 2 months or longer postintervention.

RESULTS

Frail patients had lower survival (63 ± 10% vs 94 ± 3% at 1 year, P = 0.012) and experienced significantly longer intensive care unit (11 vs 5 days, P = 0.002) and hospital (49 vs 25 days, P = 0.003) length of stay after surgical intervention compared with nonfrail patients. Twelve of 13 frail patients improved their frailty score after VAD (4.0 ± 0.8 to 1.4 ± 1.1, P < 0.001) and 12 of 13 frail patients improved their frailty score after HTx (3.2 ± 0.4 to 0.9 ± 0.9, P < 0.001). Handgrip strength and depression improved postintervention. Only a slight improvement in cognitive function was seen postintervention.

CONCLUSIONS

Frail patients with advanced heart failure experience increased mortality and morbidity after surgical intervention with BTT-VAD or HTx. Among those who survive frailty is partly or completely reversible underscoring the importance of considering this factor as a dynamic not fixed entity.

Item Type: Article
Additional Information: This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0(CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
Subjects: R Medicine > R Medicine (General)
Depositing User: Repository Administrator
Date Deposited: 20 Jul 2017 06:21
Last Modified: 20 Jul 2017 06:21
URI: https://eprints.victorchang.edu.au/id/eprint/606

Actions (login required)

View Item View Item